Transcranial Direct Current Stimulation to Enhance Cognition in Mild Cognitive Impairment

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by The University of New South Wales
Sponsor:
Information provided by (Responsible Party):
Melissa Pigot, The University of New South Wales
ClinicalTrials.gov Identifier:
NCT01653431
First received: July 30, 2012
Last updated: August 11, 2014
Last verified: August 2014

July 30, 2012
August 11, 2014
January 2013
December 2016   (final data collection date for primary outcome measure)
California Verbal Learning Test II [ Time Frame: Post treatment ] [ Designated as safety issue: No ]
California Verbal Learning Test II
Complete list of historical versions of study NCT01653431 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Transcranial Direct Current Stimulation to Enhance Cognition in Mild Cognitive Impairment
Not Provided

The study will examine whether the effects of computerized brain training are enhanced when training is combined with mild brain stimulation in patients with mild cognitive impairment. We hypothesize that this combination will produce greater improvements in cognitive functioning than computerized brain training alone.

Not Provided
Interventional
Phase 1
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Treatment
Mild Cognitive Impairment
Device: Transcranial direct current stimulation
  • Experimental: Transcranial direct current stimulation
    Transcranial direct current stimulation combined with cognitive training
    Intervention: Device: Transcranial direct current stimulation
  • Sham Comparator: Sham transcranial direct current stimulation
    Sham transcranial direct current stimulation combined with cognitive training
    Intervention: Device: Transcranial direct current stimulation
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
100
Not Provided
December 2016   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Aged 60 - 85 years.
  • Meet diagnostic criteria for amnestic mild cognitive impairment.

Exclusion Criteria:

  • Inability to provide informed consent.
  • Concurrent medication likely to affect mental performance.
  • Current substance use or dependence in last 3 months.
  • Current active psychiatric or neurological condition
Both
60 Years to 85 Years
Yes
Contact: Donel M Martin, PhD 61 2 9382 9261 donel.martin@unsw.edu.au
Australia
 
NCT01653431
HC12381
Not Provided
Melissa Pigot, The University of New South Wales
The University of New South Wales
Not Provided
Not Provided
The University of New South Wales
August 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP